| 2024-04-01 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | Chief Discovery/Trans Medicine | 6,000 0.0048% | $28.03 | $168,180 | -12.57% | |
| 2024-01-12 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | Chief Discovery/Trans Medicine | 7,940 0.0075% | $36.89 | $292,904 | -27.47% | |
| 2024-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 32,143 0.0295% | $35.18 | $1.13M | -23.8% | ||
| 2024-01-03 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 6,300 0.0059% | $32.19 | $202,781 | -13.66% | ||
| 2023-06-30 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 3,000 0.0028% | $35.53 | $106,590 | -21.55% | ||
| 2023-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 13,803 0.013% | $37.40 | $516,232 | -17.96% | |
| 2023-01-03 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 10,338 0.0097% | $38.38 | $396,738 | -20.98% | |
| 2022-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 6,250 0.0061% | $61.72 | $385,773 | -34.2% | ||
| 2022-01-04 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 19,375 0.0185% | $65.49 | $1.27M | -39.08% | ||
| 2021-01-14 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 10,000 0.0094% | $81.29 | $812,942 | -17.84% | ||
| 2021-01-06 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 19,375 0.0182% | $72.48 | $1.4M | -7.92% | ||
| 2021-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | 19,375 0.0186% | $72.53 | $1.41M | -5.41% |